Circulating Cell-Free Tumor DNA Market Poised to Grow Substantially due to Rising Adoption for Liquid Biopsy Applications
Circulating cell-free tumor DNA (ctDNA) refers to fragments of tumor DNA that are released into the bloodstream from cancer cells as they die. These ctDNA fragments carry genetic alterations that are characteristic of the tumor. The analysis of ctDNA provides a noninvasive method known as liquid biopsy for the detection and monitoring of cancers. It helps physicians learn about a...
0 Commentarii 0 Distribuiri 914 Views 0 previzualizare
Sponsor